GlassScriptPhysician profile
Gerrit Henry
NPI 1194781294
$855.23
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $43.76 · 2021: $210 · 2022: $217 · 2023: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $215.74 | 2019-2023 | |
| Incyte Corporation | $98.08 | 2022-2023 | Opzelura |
| Genzyme Corporation | $73.76 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $65.72 | 2019-2022 | |
| Amgen INC. | $58.17 | 2021-2023 | Otezla |
| Galderma Laboratories, L.P. | $51.27 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $39.31 | 2022-2023 | Libtayo |
| Leo Pharma INC. | $34.24 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.68 | 2021 | |
| Strata Skin Sciences, INC. | $22.34 | 2022 | |
| Janssen Biotech, INC. | $21.69 | 2021 | |
| Pfizer INC. | $20.85 | 2021 | |
| Dermira, INC. | $20.67 | 2019 | |
| Arcutis Biotherapeutics, INC. | $20.67 | 2023 | |
| Sun Pharmaceutical Industries INC. | $20.38 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $19.37 | 2023 | Sotyktu |
| Dermavant Sciences, INC. | $18.33 | 2023 | Vtama |
| Dusa Pharmaceuticals, INC. | $17.15 | 2019 | |
| Lilly USA, LLC | $13.81 | 2023 | Taltz, Olumiant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerrit Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.